favipiravir
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
Hangzhou Dragonpharm
Hangzhou, Zhejiang, Chinadragonpharm.com.cn ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Hangzhou Dragonpharm is a commercial-stage pharmaceutical service enterprise specializing in the development, registration, trading, and export of active pharmaceutical ingredients (APIs) and finished dosage forms. The company has a strong regulatory affairs team with experience in both domestic Chinese and international drug registrations. It supports DMF filings overseas and compliance with GMP audits. Its portfolio includes APIs for high-profile antivirals such as favipiravir and remdesivir.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Llc Technology Of MedicinesJsc R Pharm
Beyond the preview
Go deeper on Hangzhou Dragonpharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hangzhou Dragonpharm.